WNBA's New CBA Boosts Player Salaries Significantly
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy NKE?
Source: CNBC
- Salary Structure Transformation: The new CBA raises the average player salary to $583,000 by 2026, with projections exceeding $1 million by 2032, marking a significant advancement in female athletes' compensation and enhancing their economic standing.
- Maximum Salary Cap: The agreement sets the maximum salary at $1.4 million in 2026, potentially rising to $2.4 million by 2032, which is expected to retain top talent in the WNBA and reduce the trend of players seeking overseas opportunities.
- Impact on Career Choices: With improved salary structures, players will have greater flexibility in their off-season activities, as Ogwumike noted that linking salaries to business revenue will alter players' professional choices and lifestyles.
- Trust in League Leadership: Despite some players expressing dissatisfaction with WNBA Commissioner Cathy Engelbert's communication, Ogwumike remains optimistic about collaboration under the new CBA, emphasizing the historical progress achieved through player and leadership cooperation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NKE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NKE
Wall Street analysts forecast NKE stock price to rise
21 Analyst Rating
14 Buy
7 Hold
0 Sell
Moderate Buy
Current: 51.370
Low
62.00
Averages
76.11
High
110.00
Current: 51.370
Low
62.00
Averages
76.11
High
110.00
About NKE
NIKE, Inc. is engaged in the designing, marketing and distributing of athletic footwear, apparel, equipment and accessories and services for sports and fitness activities. The Company's operating segments include North America; Europe, Middle East & Africa (EMEA); Greater China; and Asia Pacific & Latin America (APLA). It sells a line of equipment and accessories under the NIKE Brand name, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment and other equipment designed for sports activities. It also designs products specifically for the Jordan Brand and Converse. The Jordan Brand designs, distributes and licenses athletic and casual footwear, apparel and accessories predominantly focused on basketball performance and culture using the Jumpman trademark. The Company also designs, distributes and licenses casual sneakers, apparel and accessories under the Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell trademarks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nike Set to Report Earnings, Market Expects Flat Revenue
- Earnings Expectations: Nike is set to report earnings after the bell this Tuesday, with the market anticipating flat revenue year-on-year, an improvement from the 9.3% decline recorded in the same quarter last year, indicating the company's ability to maintain stability in adversity.
- Revenue Performance: Last quarter, Nike reported revenues of $12.43 billion, flat year-on-year but exceeding analyst expectations, demonstrating the company's resilience and appeal in a competitive market.
- Analyst Confidence: Over the past 30 days, analysts covering Nike have generally reaffirmed their estimates, reflecting confidence in the company's future performance, despite Nike missing Wall Street's revenue estimates multiple times over the past two years.
- Market Environment: Nike's stock has declined by 16.1% over the past month, while the average drop for consumer discretionary stocks is 7.5%, reflecting market concerns and competitive pressures facing Nike.
See More
Market Dynamics and Investment Opportunities Analysis
- Market Opening Outlook: The S&P 500 is set for a higher open as President Trump signals progress in U.S.-Iran war talks, reflecting investor optimism despite typically rising oil prices dragging down stocks, indicating a potential shift in market sentiment.
- S&P 500 Performance Review: The S&P 500 has faced nearly a 6% decline in March, marking its fifth consecutive weekly loss, yet it narrowly avoids entering correction territory, with upcoming job reports expected to provide insights into economic health.
- Meta Platforms Investment Advice: Morgan Stanley recommends buying Meta Platforms, asserting that sentiment has bottomed out, and despite the company facing two litigation losses last week that impacted stock prices, early trading shows a slight recovery, indicating renewed investor confidence.
- Oracle's Positive Outlook: Bernstein analysts view Oracle's cloud and database sectors as potential AI winners, setting a price target of $319, which is more than double Friday's closing price of nearly $140, reflecting strong market confidence in its growth prospects.
See More
Surging Oil Prices Impact Market Sentiment
- Oil Price Volatility: Crude oil prices surged 55% in March following Trump's threat to 'take the oil in Iran,' marking the largest monthly gain ever, which has heightened concerns about the potential impact on the U.S. economy and market sentiment.
- Government Shutdown Impact: Trump signed an executive order to ensure TSA employees are paid after Congress failed to reach a deal, which may lead to longer security wait times and higher airfare for travelers, further affecting consumer confidence.
- Tech Industry Legal Risks: Meta's two courtroom defeats reveal the legal liabilities tech companies face when researching product impacts, which could have significant implications for the AI industry, prompting firms to reassess the risks versus rewards of such research investments.
- Pharmaceutical Collaboration: Eli Lilly's $2.75 billion deal with Insilico Medicine aims to bring AI-developed drugs to the global market, which not only boosted Lilly's stock price but also highlights the rapidly growing potential of AI applications in the pharmaceutical sector.
See More
Stock Futures Rise Amid Oil Price Surge and Market Recovery
- Oil Price Surge: Crude oil prices skyrocketed by 55% in March following Trump's threat to seize Iranian oil, marking the largest monthly gain ever, which pressures the U.S. economy and forces companies to adjust pricing strategies to cope with rising costs.
- Market Recovery Signal: Despite the S&P 500 and Nasdaq Composite experiencing their worst week of 2026, stock futures rose after Trump indicated “great progress” in negotiations with Iran, reflecting investor optimism about market recovery.
- TSA Employee Pay Restoration: Trump signed an executive order ensuring Transportation Security Administration employees will receive pay after Congress failed to reach a deal to end the government shutdown, alleviating traveler frustrations caused by long security wait times.
- AI Drug Development Partnership: Eli Lilly struck a $2.75 billion deal with Insilico Medicine to bring AI-developed drugs to market, enhancing Lilly's market confidence and potentially accelerating the application of AI in the pharmaceutical industry.
See More
Nike Earnings Preview: Focus on Demand Trends in China
- Earnings Expectations: Nike is projected to report third-quarter revenue of $11.2 billion and EPS of $0.28, down from $0.54 last year, indicating market challenges and demand fluctuations.
- Market Focus: Investors will closely watch Nike's updates on demand trends in China and the outlook for margins amid new headwinds, particularly with the World Cup being hosted in the U.S. potentially acting as a market catalyst.
- Strategic Repositioning Progress: Analysts note that Nike's management is accelerating decision-making in response to internal and external challenges, particularly showing gradual progress in the North American market, reflecting the company's efforts in business restructuring.
- Investor Sentiment: Despite mixed views among analysts regarding Nike's outlook, there is a consensus that the company is taking necessary steps to improve its business trajectory, especially through leadership appointments and efficiency enhancements that should aid margin recovery.
See More
Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
See More
Nike Set to Report Earnings, Market Expects Flat Revenue
- Earnings Expectations: Nike is set to report earnings after the bell this Tuesday, with the market anticipating flat revenue year-on-year, an improvement from the 9.3% decline recorded in the same quarter last year, indicating the company's ability to maintain stability in adversity.
- Revenue Performance: Last quarter, Nike reported revenues of $12.43 billion, flat year-on-year but exceeding analyst expectations, demonstrating the company's resilience and appeal in a competitive market.
- Analyst Confidence: Over the past 30 days, analysts covering Nike have generally reaffirmed their estimates, reflecting confidence in the company's future performance, despite Nike missing Wall Street's revenue estimates multiple times over the past two years.
- Market Environment: Nike's stock has declined by 16.1% over the past month, while the average drop for consumer discretionary stocks is 7.5%, reflecting market concerns and competitive pressures facing Nike.
See More
Market Dynamics and Investment Opportunities Analysis
- Market Opening Outlook: The S&P 500 is set for a higher open as President Trump signals progress in U.S.-Iran war talks, reflecting investor optimism despite typically rising oil prices dragging down stocks, indicating a potential shift in market sentiment.
- S&P 500 Performance Review: The S&P 500 has faced nearly a 6% decline in March, marking its fifth consecutive weekly loss, yet it narrowly avoids entering correction territory, with upcoming job reports expected to provide insights into economic health.
- Meta Platforms Investment Advice: Morgan Stanley recommends buying Meta Platforms, asserting that sentiment has bottomed out, and despite the company facing two litigation losses last week that impacted stock prices, early trading shows a slight recovery, indicating renewed investor confidence.
- Oracle's Positive Outlook: Bernstein analysts view Oracle's cloud and database sectors as potential AI winners, setting a price target of $319, which is more than double Friday's closing price of nearly $140, reflecting strong market confidence in its growth prospects.
See More
Surging Oil Prices Impact Market Sentiment
- Oil Price Volatility: Crude oil prices surged 55% in March following Trump's threat to 'take the oil in Iran,' marking the largest monthly gain ever, which has heightened concerns about the potential impact on the U.S. economy and market sentiment.
- Government Shutdown Impact: Trump signed an executive order to ensure TSA employees are paid after Congress failed to reach a deal, which may lead to longer security wait times and higher airfare for travelers, further affecting consumer confidence.
- Tech Industry Legal Risks: Meta's two courtroom defeats reveal the legal liabilities tech companies face when researching product impacts, which could have significant implications for the AI industry, prompting firms to reassess the risks versus rewards of such research investments.
- Pharmaceutical Collaboration: Eli Lilly's $2.75 billion deal with Insilico Medicine aims to bring AI-developed drugs to the global market, which not only boosted Lilly's stock price but also highlights the rapidly growing potential of AI applications in the pharmaceutical sector.
See More
Stock Futures Rise Amid Oil Price Surge and Market Recovery
- Oil Price Surge: Crude oil prices skyrocketed by 55% in March following Trump's threat to seize Iranian oil, marking the largest monthly gain ever, which pressures the U.S. economy and forces companies to adjust pricing strategies to cope with rising costs.
- Market Recovery Signal: Despite the S&P 500 and Nasdaq Composite experiencing their worst week of 2026, stock futures rose after Trump indicated “great progress” in negotiations with Iran, reflecting investor optimism about market recovery.
- TSA Employee Pay Restoration: Trump signed an executive order ensuring Transportation Security Administration employees will receive pay after Congress failed to reach a deal to end the government shutdown, alleviating traveler frustrations caused by long security wait times.
- AI Drug Development Partnership: Eli Lilly struck a $2.75 billion deal with Insilico Medicine to bring AI-developed drugs to market, enhancing Lilly's market confidence and potentially accelerating the application of AI in the pharmaceutical industry.
See More
Nike Earnings Preview: Focus on Demand Trends in China
- Earnings Expectations: Nike is projected to report third-quarter revenue of $11.2 billion and EPS of $0.28, down from $0.54 last year, indicating market challenges and demand fluctuations.
- Market Focus: Investors will closely watch Nike's updates on demand trends in China and the outlook for margins amid new headwinds, particularly with the World Cup being hosted in the U.S. potentially acting as a market catalyst.
- Strategic Repositioning Progress: Analysts note that Nike's management is accelerating decision-making in response to internal and external challenges, particularly showing gradual progress in the North American market, reflecting the company's efforts in business restructuring.
- Investor Sentiment: Despite mixed views among analysts regarding Nike's outlook, there is a consensus that the company is taking necessary steps to improve its business trajectory, especially through leadership appointments and efficiency enhancements that should aid margin recovery.
See More
Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
See More
